NESTLING BEHAVIOR and PARENTAL CARE of THE COMMON POTOO (NYCTIBIUS GRISEUS) IN SOUTHEASTERN BRAZIL

We recorded and quantified the nocturnal activity and parental care of a brooding Common Potoo (Nyctibius griseus) using an infrared camera in southeastern Brazil. Parents alternated care of the nestling and decreased their presence as the nestling grew. Nestling feeding on passing insects while sitting on the nest, movements on the nest, wing exercising, preening, and defecating were recorded primarily while it was alone. The frequency of begging calls per hour was higher when the nestling was accompanied by one of the parents. Nocturnal recordings of this species on the nest revealed behaviors that were not cited in past studies, including: feedings bouts on passing flies performed by the nestling and adults, nestling defecation, and nestling plumage maintenance. The well-known plus newly quantified behaviors of the Common Potoo reinforce their value to survival during the long nestling period. Received 24 May 2010. Accepted 14 September 2010.

Infliximabe no tratamento inicial da retocolite ulcerativa moderada e grave. Terapia top down: Relato preliminar

The first option for the treatment of UC is both: salicylates or corticoids. Recently, in late November of 2006, the Brazilian Ministry of Health has approved infliximab (Remicade c, Mantecorp, Brazil) to treat ulcerative colitis. We report the use of infliximab as a first option for the treatment of two patients with severe ulcerative colitis. Case report: Patient 1: AZF, 52 years-old, female, was first diagnosed with UC after history and clinical examination; colonoscopy showed pancolitis with positive biopsy (crypt microabscess). Her Mayo score was 10 (range: 0 to 12/asymptomatic to severe colitis). She received intra venous infusion of infliximab at a dose of 5mg/Kg of body weigh at week 0, 2, 6 and 14. Then, patient was given mesalazine 4.5 g/day for maintenance therapy. Clinical response was defined as a decreased from baseline in the total Mayo score of at least 3 points. At present, patient is asymptomatic with Mayo score of 3 one moth after the last dose of infliximab. Patient 2: MLA, 45 years-old, female was first diagnosed with bloody diarrhea; colonoscopy showed left colitis and the biopsy was positive for ulcerative colitis. Her Mayo score was 9. She was offered and accepted the step down treatment. She was given infliximab 5mg/Kg of body weight at week 0, 2, 6 and 14. After initial treatment with infliximab, she received mesalazine 4.2 g/day. At present, she is asymptomatic with Mayo score of 2 eighteen days after the last dose of infliximab. At our knowledge, this is the first Brazilian report of the use of infliximab as fist-line therapy in ulcerative colitis. Few days after the begging of the infusion, an impressive clinical and colonoscopy improvement was seen in these two patients. Recently, it has been reported the use of infliximab as first-line therapy in pediatric Crohn disease. Infliximab could be a good option in cases of moderate and severe UC to avoid the side effects of the use of high doses of corticoids in patients with moderate and severe UC. However, the question if step-down therapy in ulcerative colitis is better then conventional therapy with salicylates and corticoids needs to be answered by randomized trials.

Avaliação cardíaca de cães com degeneração valvar mixomatosa durante o emprego de enalapril, losartana, furosemida e suas combinações

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Germanismo e nazismo na colônia alemã de Presidente Venceslau (1923-1945)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Os sentidos da ciência no cenário industrial: a inovação tecnológica e suas implicações na política de educação superior

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)